Bootsma A H, de Klein A, Reubi J C, Zwarthoff E C, Lamberts S W
Department of Internal Medicine III, Erasmus University, Rotterdam, The Netherlands.
J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):829-32. doi: 10.1016/0960-0760(90)90427-m.
Forty-nine primary breast tumors were analyzed for the expression of the somatostatin receptor (SSR) and genetic changes in the RB tumor suppressor gene. Twenty-four tumor samples were shown to contain receptors for somatostatin and in eight of these SSR-positive tumors we observed a mutation in the RB gene. However, since also in the group of SSR-negative tumors in eight of the 25 cases an alteration of the RB gene was observed, loss of this tumor suppressor gene is not specific for the SSR-positive subgroup of breast tumors. A similar, equal distribution between SSR-positive and SSR-negative breast tumors was observed for the six tumor samples which showed amplification of the neu proto-oncogene.
对49例原发性乳腺肿瘤进行了生长抑素受体(SSR)表达及RB肿瘤抑制基因的基因变化分析。24个肿瘤样本显示含有生长抑素受体,在这些SSR阳性肿瘤中的8例中,我们观察到RB基因发生突变。然而,由于在25例SSR阴性肿瘤组中也有8例观察到RB基因改变,因此该肿瘤抑制基因的缺失并非乳腺肿瘤SSR阳性亚组所特有。对于显示neu原癌基因扩增的6个肿瘤样本,在SSR阳性和SSR阴性乳腺肿瘤之间观察到类似的、均等的分布。